VBIV Message Board Post 9187002 | VBI Vaccines Inc.
home / stock / vbiv / vbiv message board
Jordan12
(investorshub)
Posted on: Apr/05/2022 12:34:04
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168446939
VBI Vaccines Offers Updated Clinical, Preclinical Data From
News, Short Squeeze, Breakout and More Instantly...
-
Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response (PR) and two stable disease (SD) observations have occurred as of May 15, 2024 The partial response, which demonstrated a 67% reduction in tumor size vs. baseline, wa...
-
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the ongoing randomized, controlled Phase 2b study of VBI-1901, the Company’s ca...
-
PreHevbrio ® (Hepatitis B Vaccine [Recombinant]) global net revenue increased 105% year-over-year in the first quarter of 2024 compared to the first quarter of 2023 Initial encouraging tumor response data from randomized Phase 2b study of VBI-1901 in recurrent glioblastoma (GBM) anno...